Le Lézard
Classified in: Health
Subject: SVY

Global eBike Market Analysis & Trends 2017-2027: Increasing Investments on Research and Development by Several Market Players


DUBLIN, June 18, 2018 /PRNewswire/ --

The "Global e Bike Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global eBike Market is poised to grow strong during the forecast period 2017 to 2027

Some of the prominent trends that the market is witnessing include increasing investments on the research and development by several market players, declining LI-ION battery prices and implementation of battery management systems in e-bikes.

Scope of the Report

Report Highlights:

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 e Bike Market, By Product Type

5 e Bike Market, By Type

6 e Bike Market, By Type of Battery

7 e Bike Market, By Conversion Kit

8 e Bike Market, By Channel

9 e Bike Market, By Industry

10 e Bike Market, By Geography

11 Key Player Activities

12 Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/gq6s85/global_e_bike?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: